Hepatitis C is less aggressive in hemodialysis patients than in nonuremic patients

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 5, 2008, Pages 1385-1390

  Trevizoli, Jose Eduardo ^a,b   de Paula Menezes, Raissa ^a   Velasco, Lara Franciele Ribeiro ^c   Amorim, Regina ^d   de Carvalho, Mauro Birche ^a   Mendes, Liliana Sampaio ^a   Neto, Columbano Junqueira ^a   de Deus Macedo, José Roberto ^e   de Assis Rocha Neves, Francisco ^d  

^a HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

^b UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^c Sabin Institute and Laboratory of Clinical Analysis   (Brazil)

^d UNIVERSITY OF BRASILIA   (Brazil)

^e Hospital Santa Luzia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AUTACOID;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; DISEASE COURSE; ENZYMOLOGY; FEMALE; HEPATITIS C; HOSPITALIZATION; HUMAN; LIVER; LIVER CIRRHOSIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RENAL REPLACEMENT THERAPY; RISK; RISK ASSESSMENT; RISK FACTOR; UREMIA; VIROLOGY; VIRUS LOAD;

ADULT; AGED; ALANINE TRANSAMINASE; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ODDS RATIO; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UREMIA; VIRAL LOAD;

EID: 53749108083     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01330308     Document Type: Article

References (31)

1. Fabrizi F, Poordad FF, Martin P: Hepatitis C infection and the patient with end-stage renal disease. Hepatology 36: 3-10, 2002
2. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH: Hepatitis C and renal disease: an update. Am J Kidney Dis 42:631-657, 2003
3. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G: Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant 5: 2433-2440, 2005
4. Gane E, Pilmore H: Management of chronic viral hepatitis before and after renal transplantation. Transplantation 74: 427-437, 2002
5. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G: Meta-analysis: effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther 20: 1271-1277, 2004
6. Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 11: 1896-1902, 2000
7. Pereira BJ, Natov SN, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, Levey AS: Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease: the New England Organ Bank Hepatitis C Study Group. Kidney Int 53: 1374-1381, 1998
8. Barril G: Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15[Suppl 8]: 42-45, 2000
9. Cotler SJ, Diaz G, Gundlapalli S, Jakate S, Chawla A, Mital D, Jensik S, Jensen DM: Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol 35: 191-195, 2002
10. Glicklich D, Thung SN, Kapoian T, Tellis V, Reinus JF: Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients. Am J Gastroenterol 94: 159-163, 1999
11. Hu KQ, Lee SM, Hu SX, Xia VW, Hillebrand DJ, Kyulo NL: Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function. Am J Gastroenterol 100: 2010-2018, 2005
12. Luzar B, Ferlan-Marolt V, Brinovec V, Lesnicar G, Klopcic U, Poljak M: Does e nd-stage kidney failure influence hepatitis C progression i n hemodialysis patients? Hepatogastroenterology 50: 157-160, 2003
13. Martin P, Carter D, Fabrizi F, Dixit V, Conrad AJ, Artinian L, Peacock V, Han S, Wilkinson A, Lassman CR, Danovitch G: Histopathological features of hepatitis C in renal transplant candidates [see comment]. Transplantation 69: 1479-1484, 2000
14. Sezer S, Ozdemir BH, Arat Z, Turan M, Ozdemir NF, Haberal M: Spectrum of liver damage and correlation with clinical and laboratory parameters in HCV infected hemodialysis patients. Ren Fail 23: 807-818, 2001
15. Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, Mills AS, Contos MJ, Shiffman ML: Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 94: 3576-3582, 1999
16. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C: the METAVIR Cooperative Study Group. Hepatology 24: 289-293, 1996
17. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Aljama P: Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients. Nephrol Dial Transplant 16: 1669-1674, 2001
18. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ: Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 32: 629-634, 1998
19. Perez RM, Ferreira AS, Medina-Pestana JO, Cendoroglo-Neto M, Lanzoni VP, Silva EB, Ferraz ML: Is hepatitis C more aggressive in renal transplant patients than in patients with end-stage renal disease? J Clin Gastroenterol 40: 444-448, 2006
20. Lemos LB, Perez RM, Lemos MM, Lanzoni VP, Draibe SA, Silva IS, Silva AE, Ferraz ML: Hepatitis C in chronic kidney disease: predialysis patients present more severe histological liver injury than hemodialysis patients? Am J Nephrol 27: 191-196, 2007
21. Alric L, Di-Martino V, Selves J, Cacoub P, Charlotte F, Reynaud D, Piette JC, Péron JM, Vinel JP, Durand D, Izopet J, Poynard T, Duffaut M, Rostaing L: Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection. Gastroenterology 123: 1494-1499, 2002
22. Kamar N, Rostaing L, Selves J, Sandres-Saune K, Alric L, Durand D, Izopet J: Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 5: 1704-1712, 2005
23. Scamps-Latscha B, Chatenoud L: T cells and B cells in chronic renal failure. Semin Nephrol 16: 183-191, 1996
24. Yoon JW, Gollapudi S, Pahl MV, Vaziri ND: Naive and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int 70: 371-376, 2006
25. Rampino T, Arbustini E, Gregorini M, Guallini P, Libetta C, Maggio M, Ranghino A, Silini E, Soccio G, Dal Canton A: Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor. Kidney Int 56: 2286-2291, 1999
26. Sezer S, Tutal E, Aldemir D, Türkoglu S, Demirel OU, Afsar B, Ozdemir FN, Haberal M: Hepatitis C infection in hemodialysis patients: protective against oxidative stress? Transplant Proc 38: 406-410, 2006
27. Fontaine H, Nalpas B, Poulet B, Carnot F, Zylberberg H, Brechot C, Pol S: Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C. Hum Pathol 32: 904-909, 2001
28. Fabrizi F, Bunnapradist S, Lunghi G, Martin P: Kinetics of hepatitis C virus load during hemodialysis: novel perspectives. J Nephrol 16: 467-475, 2003
29. Mizuno M, Higuchi T, Yanai M, Kanmatsuse K, Esumi M: Dialysis-membrane-dependent reduction and adsorption of circulating hepatitis C virus during hemodialysis. Nephron 91: 235-242, 2002
30. Badalamenti S, Catania A, Lunghi G, Covini G, Bredi E, Brancaccio D, Salvadori M, Como G, Ponticelli C, Graziani G: Changes in viremia and circulating interferon-alpha during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena? Am J Kidney Dis 42:143-150, 2003
31. Massard J, Ratziu V, Thabut D, Moussalli J, Lebray P, Benhamou Y, Poynard T: Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol 44[Suppl]: S19-S24, 2006